Back
United Therapeutics Stock Price Chart

Mode Mobile Could be Next in Line"
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
49
UTHR
United Therapeutics
Last Price:
$280.70
Seasonality Move:
4.96%
7 Day Trial
ALL ACCESS PASS
$
7

[Urgent Alert] This unique trade could land you 100% gains in 10 days
Discover how much you can make with this "Friday Phenomenon."-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and UTHR is experiencing slight buying pressure.
United Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 292.04 | Sell |
20-day SMA: | 304.82 | Sell |
50-day SMA: | 326.51 | Sell |
200-day SMA: | 346.03 | Sell |
8-day EMA: | 290.11 | Sell |
20-day EMA: | 301.65 | Sell |
50-day EMA: | 320.58 | Sell |
200-day EMA: | 329.05 | Sell |
United Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -11.65 | Sell |
Relative Strength Index (14 RSI): | 34.64 | Sell |
Chaikin Money Flow: | 64767 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (293.28 - 317.64) | Sell |
Bollinger Bands (100): | (317.85 - 375.31) | Sell |
United Therapeutics Technical Analysis
Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | Apr | |||||||||
31 | 01 | 02 | 03 | 04 | 07 | 08 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for United Therapeutics Stock
Is United Therapeutics Stock a Buy?
-
United Therapeutics share price is 281.16 while UTHR 8-day simple moving average is 292.04, which is a Sell signal.
-
The stock price of UTHR is 281.16 while United Therapeutics 20-day SMA is 304.82, which makes it a Sell.
-
United Therapeutics 50-day simple moving average is 326.51 while UTHR share price is 281.16, making it a Sell technically.
-
UTHR stock price is 281.16 and United Therapeutics 200-day simple moving average is 346.03, creating a Sell signal.
UTHR Technical Analysis vs Fundamental Analysis
Sell
49
United Therapeutics (UTHR)
is a Sell
Is United Therapeutics a Buy or a Sell?
-
United Therapeutics stock is rated a SellThe current United Therapeutics [UTHR] share price is $281.16. The Score for UTHR is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
United Therapeutics Stock Info
Market Cap:
12.6B
Price in USD:
281.16
Share Volume:
670.8K
United Therapeutics 52-Week Range
52-Week High:
417.82
52-Week Low:
230.39
Sell
49
United Therapeutics (UTHR)
is a Sell
United Therapeutics Share Price Forecast
-
What is the United Therapeutics stock price today?The United Therapeutics stock price is 281.16 USD today.
-
Will UTHR stock go up or go down?United Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is United Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, United Therapeutics is overvalued.
Is United Therapeutics Stock a Buy?
-
United Therapeutics share price is 281.16 while UTHR 8-day exponential moving average is 290.11, which is a Sell signal.
-
The stock price of UTHR is 281.16 while United Therapeutics 20-day EMA is 301.65, which makes it a Sell.
-
United Therapeutics 50-day exponential moving average is 320.58 while UTHR share price is 281.16, making it a Sell technically.
-
UTHR stock price is 281.16 and United Therapeutics 200-day simple moving average is 329.05, creating a Sell signal.
Fundamental Analysis of United Therapeutics
Is United Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.78 per share, a decrease next quarter of $0.81 per share, an increase this year of $2.40 per share, and an increase next year of $0.56 per share.
Technical Analysis of United Therapeutics
Should I short United Therapeutics stock?
-
UTHR Moving Average Covergence Divergence (MACD) indicator is -11.65, suggesting United Therapeutics is a Sell
-
United Therapeutics Relative Strength Index (RSI) is 34.64, which suggest United Therapeutics is oversold
-
The Bollinger Bands (25) for United Therapeutics is (293.28 - 317.64), which suggest United Therapeutics is a Sell
-
The Bollinger Bands (100) for United Therapeutics is (317.85 - 375.31), which suggest United Therapeutics is a Sell
* United Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.